CBS Cancels The Late Show with Stephen Colbert Networks LateNight Strategy Shifts to Comics Unleashed Jim Cramers Latest Claim on CrowdStrike Sparks Market Speculation Oil Markets Near Tipping Point as USIran Talks Accelerate Potential Impact on Global Economy The Number of 401k Millionaires Declined While Savings Hit a Record A Market Paradox Podcast Hall of Fame Inductees Signal Industrys Strategic Direction A Financial Perspective US FirstQuarter GDP Revised Down to 16 What the Revised Data Signals About Economic Momentum Stepan Company SCL Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises Annaly Capital Management Q1 2026 Earnings EPS Slightly Beats Estimates Amid Challenging Rate Environment HELE Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction WTI Q1 2026 Earnings Significant EPS Miss as Offshore Producer Faces Headwinds ARDT Q1 2026 Earnings EPS Surges Past Expectations with 486 Beat OKUR Q1 2026 Earnings WiderthanExpected Loss Reflects RD Investment Ermenegildo Zegna ZGN Edges Lower Testing Key Support Near 1263 Mingteng International Corporation MTEN Rallies 79 as Stock Tests Key Resistance at 114 Essent Group ESNT Holds Near 6055 After Modest Decline Support and Resistance Levels in Focus PureTech Health PRTC Holds Steady at 1725 Consolidation or Calm Before a Move CeriBell Inc CBLL Modest Pullback Near Key Support Zone New York Fed Study Reveals Disproportionate Impact of Rising Gas Prices on LowerIncome Households Tony Blairs Economic Prescription for UK Draws Criticism Overreliance on AI and Outdated Worldview Dollar Holds Near SixWeek High as Middle East Tensions and Fed Uncertainty Weigh on Global Currencies Britains Energy Shock Editorial Warns MiniMeasures Insufficient Amid Iran Conflict Brookings Analysis Potential ShortRun Economic Impacts of 2025 Tariffs on US Economy Coal Remains Central to Chinas Evolving Energy Strategy Amazon Allegedly Generated Millions Through Policy Later Deemed Illegal WTW Q1 2026 Earnings EPS Slightly Beats Estimates as Stock Edges Lower Design Therapeutics DSGN Edges Higher as Support Holds Above 1060